MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.9838
+0.0038
+0.39%
Closed 16:00 02/26 EST
OPEN
0.9900
PREV CLOSE
0.9800
HIGH
1.015
LOW
0.9400
VOLUME
106.44K
TURNOVER
0
52 WEEK HIGH
4.290
52 WEEK LOW
0.8400
MARKET CAP
51.33M
P/E (TTM)
-1.8482
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CTSO last week (0219-0223)?
Weekly Report · 19h ago
Weekly Report: what happened at CTSO last week (0212-0216)?
Weekly Report · 02/19 11:28
Weekly Report: what happened at CTSO last week (0205-0209)?
Weekly Report · 02/12 11:17
Weekly Report: what happened at CTSO last week (0129-0202)?
Weekly Report · 02/05 11:25
Weekly Report: what happened at CTSO last week (0122-0126)?
Weekly Report · 01/29 11:14
Weekly Report: what happened at CTSO last week (0115-0119)?
Weekly Report · 01/22 11:19
NCAC, PTPI and CTSO among pre-market losers
NCAC, PTPI and CTSO among pre-market losers. Humana slumps 14% after cutting profit outlook on higher medical costs. Newcourt Acquisition Corp (NCAC) and Plug Power (PLUG) are among the day's losers. CVS Health Corp (CVS) is down 5%.
Seeking Alpha · 01/18 13:24
Cytosorbents Corp: Current report
Press release · 01/18 00:13
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its polymer adsorption technology. Its lead product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR, ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.